Regulation of Xenobiotic Metabolism by Orphan Nuclear Receptors

Toxicologic Pathology

Volumn 29, Issue 1, 2001, Pages 3-5

  Miller, Richard T ^a   Willson, Timothy M ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

Drug drug interaction; peroxisome proliferator; pregnane X receptor; St. John's wort

Indexed keywords

16ALPHA CYANOPREGNENOLONE; ANDROGEN RECEPTOR; ANDROSTANE DERIVATIVE; CARCINOGEN; CELL NUCLEUS RECEPTOR; CLOTRIMAZOLE; CYCLOSPORIN; CYTOCHROME P450; DNA; ESTROGEN RECEPTOR; HYPERFORIN; IMMUNOSUPPRESSIVE AGENT; INDINAVIR; ORAL CONTRACEPTIVE AGENT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PHENOBARBITAL; PROTEINASE INHIBITOR; RIFAMPICIN;

CONFERENCE PAPER; DNA BINDING; DRUG METABOLISM; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HYPERICUM PERFORATUM; MULTIGENE FAMILY; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; XENOBIOTIC METABOLISM;

ANIMALS; HUMANS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, DRUG; XENOBIOTICS;

HYPERICUM PERFORATUM;

EID: 0035145725     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1080/019262301301418801     Document Type: Article

References (20)

1. Cattley RC, DeLuca J., Elcombe C., Fenner-Crisp P., Lake BG, Mars-man DS, Pastoor TA, Popp JA, Robinson DE, Schwetz B., Tugwood J., Wahli W. (1998). Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans? Regul Toxicol Pharmacol 27: 47-60.
2. Cheema SK, Agellon LB (2000). The murine and human cholesterol 7alpha-hydroxylase gene promoters are differentially responsive to regulation by fatty acids mediated via peroxisome proliferator-activated receptor alpha. J Biol Chem 275: 12530-12536.
3. Ernst E. (1999). Second thoughts about safety of St John's wort. Lancet 354: 2014-2016.
4. Ernst E., Rand JI, Barnes J., Stevinson C. (1998). Adverse effects profi le of the herbal antidepressant St. John's wort (Hypericum perforatum L.). Eur J Clin Pharmacol 54: 589-594.
5. Fugh-Berman A. (2000). Herb-drug interactions. Lancet 355: 134 – 138.
6. Fuhr U. (2000). Induction of drug metabolising enzymes: Pharmacokinetic and toxicological consequences in humans. Clin Pharmacokinet 38: 493-504.
7. Hertz R., Bar-Tana J. (1998). Peroxisome proliferator-activated receptor (PPAR) alpha activation and its consequences in humans. Toxicol Lett 102-103: 85-90.
8. Honkakoski P., Zelko I., Sueyoshi T., Negishi M. (1998). The nuclear orphan receptor CAR-retinoid X receptor heterodimer activates the phenobarbital-responsive enhancer module of the CYP2B gene. Mol Cell Biol 18: 5652-5658.
9. Jones SA, Moore LB, Shenk JL, Wisely GB, Hamilton GA, McKee DD, Nicholas CO, Tomkinson NCO, LeCluyse EL, Lambert MH, Willson TM, Kliewer SA, Moore, JT (2000). The pregnane X receptor: A promiscuous xenobiotic receptor. Mol Endocrinol 14: 27-39.
10. Kliewer SA, Lehmann JM, Willson TM (1999). Orphan nuclear receptors: Shifting endocrinology into reverse. Science 284: 757-760.
11. Kliewer SA, Moore JT, Wade L., Staudinger JL, Watson MA, Jones SA, McKee DD, Oliver BB, Willson TM, Zetterstrom RH, Perlmann T., Lehmann JM (1998). An orphan nuclear receptor activated by pregnane s defi nes a novel steroid signaling pathway. Cell 92: 73-82.
12. Lambe KG, Woodyatt NJ, Macdonald N., Chevalier S., Roberts RA (1999). Species differences in sequence and activity of the peroxisome proliferator response element (PPRE) within the acyl CoA oxidase gene promoter. Toxicol Lett 110: 119-127.
13. Lehmann JM, McKee DD, Watson MA, Willson TM, Moore JT, Kliewer SA (1998). The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J Clin Invest 102: 1016-1023.
14. Michalets EL (1998). Update: Clinically signifi cant cytochrome P-450 drug interactions. Pharmacotherapy 18: 84-112.
15. Moore, LB, Goodwin B., Jones SA, Wisely GB, Serabjit-Singh CJ, Willson TM, Collins JL, Kliewer, SA (2000). St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc Natl Acad Sci USA 97: 7500-7502.
16. Moore LB, Parks DJ, Jones SA, Bledsoe RK, Consler TG, Stimmel JB, Goodwin B., Liddle C., Blanchard SG, Willson TM, Collins JL, Kliewer SA (2000). Orphan nuclear receptors CAR and PXR share xenobiotic and steroid ligands. J Biol Chem 275: 15122-15127.
17. Piscitelli SC, Burstein AH, Chaitt D., Alfaro RM, Falloon J. (2000). Indinavir concentrations and St John's wort. Lancet 355: 547-548.
18. Rodriguez C., Noe V., Cabrero A., Ciudad CJ, Laguna JC (2000). Differences in the formation of PPARα-RXR/acoPPRE complexes between responsive and nonresponsive species upon fi brate administration. Mol Pharmacol 58: 185-193.
19. Ruschitzka F., Meier PJ, Turina M., Luscher TF, Noll G. (2000). Acute heart transplant rejection due to Saint John's wort. Lancet 355: 548-549.
20. Takada I., Yu RT, Xu HE, Lambert MH, Montana VG, Kliewer SA, Evans RM, Umesono K. (2000). Alteration of a single amino acid in peroxisome proliferator-activated receptor-alpha (PPAR α) generates a PPAR delta phenotype. Mol Endocrinol 14: 733-740.